Clincosm LogoSign in Get a demo

bladder cancer

Showing NaN - NaN of 115
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

Recruiting
  • Ovarian Cancer
  • +12 more
  • San Francisco, California
  • +44 more
Jul 12, 2022

Bladder Cancer, Urothelial Carcinoma Trial in United States (OGX-427, Docetaxel)

Completed
Has Results
  • Bladder Cancer
  • Urothelial Carcinoma
  • Birmingham, Alabama
  • +34 more
Jul 7, 2022

Bladder Cancer Trial in United States (Nivolumab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Bladder Cancer
  • Duarte, California
  • +6 more
Jul 7, 2022

Bladder Cancer Trial in Korea, Republic of, Poland, United States (PF-07225570, sasanlimab)

Recruiting
  • Bladder Cancer
  • New York, New York
  • +5 more
Jun 28, 2022

Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)

Recruiting
  • Ovarian Cancer
  • +10 more
  • West Hollywood, California
  • +27 more
Jun 27, 2022

A Genotype-Phenotype Urothelial Cancer Registry

Recruiting
  • Urothelial Cancer
  • +3 more
  • saliva sample and questionaire
  • saliva sample, questionaire
  • Basking Ridge, New Jersey
  • +3 more
Jun 2, 2022

Bladder Cancer, Melanoma Trial in United States (Nivolumab, Nivolumab plus Ipilimumab)

Active, not recruiting
  • Bladder Cancer
  • Melanoma
  • Farmington, Connecticut
  • +4 more
May 9, 2022

Bladder Cancer Trial in United States (cisplatin, 5-fluorouracil, Mitomycin)

Active, not recruiting
Has Results
  • Bladder Cancer
  • Atlanta, Georgia
  • +12 more
Mar 28, 2022

Bladder Cancer Recurrence Study (The DETER Study)

Active, not recruiting
  • Bladder Cancer
  • questionnaires
  • Saliva and/or urine sample
  • Basking Ridge, New Jersey
  • +3 more
Apr 11, 2022

Breast Cancer, Bladder Cancer, Kidney Cancer Trial in New York (PCR/PCR/LDR Strategy)

Recruiting
  • Breast Cancer
  • +6 more
  • PCR/PCR/LDR Strategy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 1, 2022

Bladder Cancer Trial in United States (external radiation therapy with gemcitabine)

Active, not recruiting
  • Bladder Cancer
  • external radiation therapy with gemcitabine
  • Basking Ridge, New Jersey
  • +4 more
Mar 9, 2022

Head and Neck Squamous Cell Carcinoma, Breast Cancer, Sarcoma Trial in United States (Durvalumab, Tremelimumab, Poly ICLC)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • +10 more
  • Atlanta, Georgia
  • +6 more
Mar 1, 2022

Solid Tumor Cancers, Lung Cancer, Bladder Cancer Trial in United States (ado-trastuzumab emtansine)

Recruiting
  • Solid Tumor Cancers
  • +3 more
  • ado-trastuzumab emtansine
  • Basking Ridge, New Jersey
  • +6 more
Mar 1, 2022

Bladder Cancer, High Risk Superficial Trial in United States (Bacillus Calmette-Guérin (BCG))

Completed
  • Bladder Cancer
  • High Risk Superficial
  • Bacillus Calmette-Guérin (BCG)
  • Basking Ridge, New Jersey
  • +4 more
Feb 28, 2022

Urothelial Carcinoma, Bladder Cancer, Urethral Cancer Trial in United States (Biospecimen Collection)

Active, not recruiting
  • Urothelial Carcinoma
  • +3 more
  • Biospecimen Collection
  • Los Angeles, California
  • +7 more
Feb 14, 2022

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022

Bladder Cancer, Non-Muscle-Invasive Urothelial Carcinoma Trial in New York (BGJ398)

Active, not recruiting
  • Bladder Cancer
  • Non-Muscle-Invasive Urothelial Carcinoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 3, 2022

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

Recruiting
  • Urothelial Carcinoma
  • +20 more
  • Gilbert, Arizona
  • +9 more
Feb 3, 2022

Bladder Cancer Trial in United States (Nivolumab, Ipilimumab, Radical cystectomy)

Recruiting
  • Bladder Cancer
  • Basking Ridge, New Jersey
  • +6 more
Feb 1, 2022

Bladder Cancer Trial in United States (Gemcitabine, Cisplatin, Methotrexate)

Active, not recruiting
Has Results
  • Bladder Cancer
  • Birmingham, Alabama
  • +565 more
Dec 3, 2021

Bladder Cancer, Metastatic Transitional Cell Carcinoma Trial in New York (Everolimus)

Completed
  • Bladder Cancer
  • Metastatic Transitional Cell Carcinoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 16, 2021

Bladder Cancer, Urothelial Carcinoma, Urinary Bladder Tumor Trial in United States (NanoDoce (direct injection), NanoDoce

Completed
  • Bladder Cancer
  • +8 more
  • NanoDoce (direct injection)
  • +3 more
  • Phoenix, Arizona
  • +4 more
Nov 29, 2021

Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in Worldwide (UGN-102, TURBT)

Active, not recruiting
  • Bladder Cancer
  • +2 more
  • Tucson, Arizona
  • +138 more
Nov 15, 2021

Bladder Cancer, Complications Trial in New York (Clear liquid diet)

Completed
  • Bladder Cancer
  • Complications
  • Clear liquid diet
  • New York, New York
  • +1 more
Aug 13, 2021

Bladder Cancer Trial in Canada, United States (Vicinium)

Active, not recruiting
  • Bladder Cancer
  • Vicinium
  • Birmingham, Alabama
  • +69 more
Jun 10, 2021